Acquisition / mergerNotableFiled on BSE ·

Aster DM Healthcare's Scheme of Amalgamation approved by NCLT Hyderabad

Aster DM Quality Care · Healthcare Services

Arthneeti Research DeskPublished 1 min read

Key highlights

  • NCLT Hyderabad sanctioned the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited on June 19, 2026
  • The Scheme approval is under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013
  • The Scheme will become effective upon filing certified NCLT order with Registrar of Companies and meeting other conditions; QCIL will dissolve without winding up

Why it's rated notable: The filing states no value for the amalgamation, so it is an internal restructuring with no stated value and is rated medium at most, with the scheme not yet effective pending filing with the Registrar of Companies.

Original filing

Order Passed By The Hon'ble National Company Law Tribunal, Hyderabad Bench, Approving The Scheme Of Amalgamation

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Aster DM Quality Care

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.